274 related articles for article (PubMed ID: 11754997)
1. Interleukin-1, neuroinflammation, and Alzheimer's disease.
Mrak RE; Griffin WS
Neurobiol Aging; 2001; 22(6):903-8. PubMed ID: 11754997
[TBL] [Abstract][Full Text] [Related]
2. The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.
Griffin WS; Nicoll JA; Grimaldi LM; Sheng JG; Mrak RE
Exp Gerontol; 2000 Jul; 35(4):481-7. PubMed ID: 10959036
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis.
Sheng JG; Ito K; Skinner RD; Mrak RE; Rovnaghi CR; Van Eldik LJ; Griffin WS
Neurobiol Aging; 1996; 17(5):761-6. PubMed ID: 8892349
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.
Griffin WS; Mrak RE
J Leukoc Biol; 2002 Aug; 72(2):233-8. PubMed ID: 12149413
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.
Griffin WS; Sheng JG; Roberts GW; Mrak RE
J Neuropathol Exp Neurol; 1995 Mar; 54(2):276-81. PubMed ID: 7876895
[TBL] [Abstract][Full Text] [Related]
6. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.
Mrak RE; Sheng JG; Griffin WS
J Neuropathol Exp Neurol; 1996 Mar; 55(3):273-9. PubMed ID: 8786385
[TBL] [Abstract][Full Text] [Related]
7. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
Sheng JG; Mrak RE; Griffin WS
Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597
[TBL] [Abstract][Full Text] [Related]
8. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism.
Grimaldi LM; Casadei VM; Ferri C; Veglia F; Licastro F; Annoni G; Biunno I; De Bellis G; Sorbi S; Mariani C; Canal N; Griffin WS; Franceschi M
Ann Neurol; 2000 Mar; 47(3):361-5. PubMed ID: 10716256
[TBL] [Abstract][Full Text] [Related]
9. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease.
Mrak RE; Griffinbc WS
Neurobiol Aging; 2001; 22(6):915-22. PubMed ID: 11754999
[TBL] [Abstract][Full Text] [Related]
10. Association of interleukin-1 gene polymorphisms with Alzheimer's disease.
Nicoll JA; Mrak RE; Graham DI; Stewart J; Wilcock G; MacGowan S; Esiri MM; Murray LS; Dewar D; Love S; Moss T; Griffin WS
Ann Neurol; 2000 Mar; 47(3):365-8. PubMed ID: 10716257
[TBL] [Abstract][Full Text] [Related]
11. Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain.
Abad MA; Enguita M; DeGregorio-Rocasolano N; Ferrer I; Trullas R
J Neurosci; 2006 Dec; 26(49):12735-47. PubMed ID: 17151277
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Calsyntenin-3 C-terminal fragment accumulates in dystrophic neurites surrounding aβ plaques in tg2576 mouse and Alzheimer disease brains: its neurotoxic role in mediating dystrophic neurite formation.
Uchida Y; Gomi F; Murayama S; Takahashi H
Am J Pathol; 2013 May; 182(5):1718-26. PubMed ID: 23499467
[TBL] [Abstract][Full Text] [Related]
14. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.
Du Y; Dodel RC; Eastwood BJ; Bales KR; Gao F; Lohmüller F; Müller U; Kurz A; Zimmer R; Evans RM; Hake A; Gasser T; Oertel WH; Griffin WS; Paul SM; Farlow MR
Neurology; 2000 Aug; 55(4):480-3. PubMed ID: 10953177
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
[TBL] [Abstract][Full Text] [Related]
16. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease.
Sodeyama N; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H; Yamada M
J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):548-51. PubMed ID: 9576554
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options.
Hüll M; Fiebich BL; Lieb K; Strauss S; Berger SS; Volk B; Bauer J
Neurobiol Aging; 1996; 17(5):795-800. PubMed ID: 8892354
[TBL] [Abstract][Full Text] [Related]
18. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms.
Sheng JG; Mrak RE; Griffin WS
Acta Neuropathol; 1997 Jul; 94(1):1-5. PubMed ID: 9224523
[TBL] [Abstract][Full Text] [Related]
19. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
Dickson TC; Vickers JC
Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
[TBL] [Abstract][Full Text] [Related]
20. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease.
Hüll M; Strauss S; Berger M; Volk B; Bauer J
Behav Brain Res; 1996 Jun; 78(1):37-41. PubMed ID: 8793035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
